Intergroupe francophone de cancérologie thoracique, Société de pneumologie de langue française, and Société d’imagerie thoracique statement paper on lung cancer screening - 31/03/21

Doi : 10.1016/j.diii.2021.01.012

Sébastien Couraud ^a,^b,⁎ , Gilbert Ferretti ^c, Bernard Milleron ^b, Alexis Cortot ^d, Nicolas Girard ^e, Valérie Gounant ^f, François Laurent ^g, Olivier Leleu ^h, Elisabeth Quoix ⁱ, Marie-Pierre Revel ^j,^k, Marie Wislez ^k,^l, Virginie Westeel ^m, Gérard Zalcman ^f,^k, Arnaud Scherpereel ^d, Antoine Khalil ^k,ⁿ
^a Acute Respiratory Disease and Thoracic Oncology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, 69310 Pierre-Bénite, France
^b Intergroupe Francophone de Cancérologie Thoracique, 75009 Paris, France
^c Department of Diagnostic and Interventional Radiology, CHU Grenoble Alpes, 38700 La Tronche, France
^d Department of Pneumology and Thoracic Oncology, CHU Lille, 59000 Lille, France
^e Department of Thoracic Oncology, Institut Curie, 75005 Paris, France
^f Department of Thoracic Oncology, Groupe Hospitalier Bichat–Claude-Bernard, Assistance publique–Hôpitaux de Paris, 75018 Paris, France
^g Department of Radiology, CHU Bordeaux, 33000 Bordeaux, France
^h Department of Pneumology, CH Abbeville, 80100 Abbeville, France
ⁱ Department of Pneumology, CHRU Strasbourg, 67200 Strasbourg, France
^j Department of Radiology, Hôpital Cochin, Assistance Publique–Hôpitaux de Paris, 75014 Paris, France
^k Université de Paris, F-75006 Paris, France
^l Department of Thoracic Oncology, Hôpital Cochin, Assistance Publique–Hôpitaux de Paris, 75014 Paris, France
^m Department of Thoracic Oncology, CHU de Besançon, 25000 Besançon, France
ⁿ Department of Radiology, Groupe Hospitalier Bichat–Claude-Bernard, Assistance publique–Hôpitaux de Paris, 75018 Paris, France

^⁎Corresponding author at: Acute Respiratory Disease and Thoracic Oncology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, 69310 Pierre-Bénite, France.Acute Respiratory Disease and Thoracic Oncology Department, Hôpital Lyon Sud, Hospices Civils de LyonPierre-Bénite69310France

conectar o crear una cuenta

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

•	The two randomized studies with patient enrollments conferring sufficient statistical power satisfactorily demonstrated the ability of low-dose computed tomography screening to significantly reduce lung cancer-specific mortality.
•	Thus, in accordance with all international guidelines, the experts renew their recommendation in favor of individual screening for lung cancer in France as per the conditions laid out in this document (grade A).
•	Considering the rarity of data on the feasibility of low-dose computed tomography screening for lung cancer in France, the experts recommend the very rapid organization and funding of prospective studies, which, if conclusive, will enable the deployment of lung cancer screening organized at the national level (grade AE).
•	Lung cancer screening should be carried out using unenhanced low-dose computed tomography (grade A).

El texto completo de este artículo está disponible en PDF.

Abstract

Following the American National Lung Screening Trial results in 2011 a consortium of French experts met to edit a statement. Recent results of other randomized trials gave the opportunity for our group to meet again in order to edit updated guidelines. After literature review, we provide here a new update on lung cancer screening in France. Notably, in accordance with all international guidelines, the experts renew their recommendation in favor of individual screening for lung cancer in France as per the conditions laid out in this document. In addition, the experts recommend the very rapid organization and funding of prospective studies, which, if conclusive, will enable the deployment of lung cancer screening organized at the national level.

El texto completo de este artículo está disponible en PDF.

Keywords : Lung neoplasm, Early detection of cancer, Multi-detector computed tomography, Solitary pulmonary nodule, Multiple pulmonary nodules

Esquema

Abbreviation

Introduction

Methods

Should lung cancer screening be proposed in France?

To whom should individual lung cancer screening be proposed?

What is the optimal duration of screening?

How frequently should screening CT be performed?

What technical procedures are necessary for screening?

How screening CT should be interpreted?

Decision-making strategy for solid nodules

Decision-making strategy for subsolid nodules

What information should be provided to eligible patients?

Conclusion

Contributors

Disclosure of interest

Fundings

Author contributions

Credit author statement

Exportación

Vol 102 - N° 4

P. 199-211 - avril 2021 Regresar al número

Artículo precedente

Lung cancer screening: French radiologists should prepare for it
Mathieu Lederlin, Constance de Margerie-Mellon, Samia Boussouar, Sébastien Bommart, Caroline Caramella

| Artículo siguiente

CT evaluation of unrepaired/incidental congenital cardiovascular diseases in adults
Arash Bedayat, Mohammad H. Jalili, Cameron Hassani, Hamid Chalian, Stefan Reuhm, John Moriarty